title: Raltegravir/nevirapine dual therapy at reduced doses as 'maintenance' treatment in virally suppressed HIV-infected patients.
authors.affiliation: aSimple Unit of 'Diagnosis and Therapy of HIV infection' bUnit of Infectious Diseases, 'G.B.Rossi' Hospital, Verona, Italy cDepartment of Internal Medicine, Faculty of Medicine, University of Botswana, Gaborone, Botswana.
authors.forename: Massimiliano
authors.initials: M
authors.lastname: Lanzafame
authors.forename: Emanuela
authors.initials: E
authors.lastname: Lattuada
authors.forename: Fabio
authors.initials: F
authors.lastname: Rigo
authors.forename: Stefano
authors.initials: S
authors.lastname: Nicole
authors.forename: Giulia
authors.initials: G
authors.lastname: Cucchetto
authors.forename: Sandro
authors.initials: S
authors.lastname: Vento
mesh_terms: D000328:Adult; D019380:Anti-HIV Agents / Q000008:administration & dosage*; D023241:Antiretroviral Therapy, Highly Active / Q000379:methods*; D018791:CD4 Lymphocyte Count; D005260:Female; D006678:HIV / Q000302:isolation & purification; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D060046:Maintenance Chemotherapy / Q000379:methods*; D008297:Male; D008875:Middle Aged; D019829:Nevirapine / Q000008:administration & dosage*; D012367:RNA, Viral / Q000097:blood; D000068898:Raltegravir Potassium / Q000008:administration & dosage*; D019562:Viral Load
chemical_list: D019380:Anti-HIV Agents; D012367:RNA, Viral; D000068898:Raltegravir Potassium; D019829:Nevirapine